March 9, 2020 / 1:48 PM / a month ago

BRIEF-Innovation Pharmaceuticals Brilacidin Received By U.S. Regional Biocontainment Laboratory Testing Against Coronavirus

March 9 (Reuters) - Innovation Pharmaceuticals Inc :

* INNOVATION PHARMACEUTICALS BRILACIDIN RECEIVED BY U.S. REGIONAL BIOCONTAINMENT LABORATORY; TESTING AGAINST CORONAVIRUS (COVID-19)

* INNOVATION PHARMACEUTICALS INC - COMPANY ANTICIPATES CONFIRMATION OF TESTING SCHEDULE AS WELL AS PROCEDURES FOR STUDIES LATER THIS WEEK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below